Review





Similar Products

99
Developmental Studies Hybridoma Bank igg2b α myhc i
Igg2b α Myhc I, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/igg2b α myhc i/product/Developmental Studies Hybridoma Bank
Average 99 stars, based on 1 article reviews
igg2b α myhc i - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

96
ATCC igg2b isotype control antibody
The Role of CD4 + T Cells in Cardiac Functional Remodeling (A) Experimental design. (B and C) Flow cytometric analysis of CD4 + T cells in peripheral blood of TCRM mice treated with <t>IgG2b</t> isotype control or anti-CD4 antibody. (D) Representative H&E and PSR-stained heart sections. (E) Myocarditis score and (F) quantification of PSR-positive area, in 8-week-old TCRM mice subjected to the indicated treatment. (G to J) Echocardiographic assessment of left ventricular morphology and function in 8-week-old TCRM mice treated with isotype control or anti-CD4 antibody. (G) LVID systole, (H) LVEF, (I) GCS, (J) GLS. (C, E to J) Pooled data from 3 independent experiments, including n = 12 anti-CD4-treated TCRM mice and n = 13 isotype-treated TCRM mice of which n = 5 progressed to iCMP. Statistical analysis was performed using C, unpaired 2-tailed Student’s t -test or Mann-Whitney U test and (E to J) 1-way analysis of variance with Tukey’s post hoc test or Kruskal-Wallis test with Dunnett’s multiple comparisons test. Boxplots as in . ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001. Abbreviations as in and .
Igg2b Isotype Control Antibody, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/igg2b isotype control antibody/product/ATCC
Average 96 stars, based on 1 article reviews
igg2b isotype control antibody - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

94
Miltenyi Biotec rat igg2b pe isotype control
Intravenous antibody labeling distinguishes CNS-resident from circulating immune cells in ACSA2 + fractions. (A) Mice received I.V. injection of fluorescent antibody 3 min before tissue harvest and brain dissociation. I.V.-labeled cells represent circulating immune cells, while unlabeled CD45 + cells are CNS-resident. Created in BioRender. Daniele, E. (2026) https://BioRender.com/20anz0d . (B) Flow cytometry using anti-CD45.2-PE (I.V.) shows 20.3% of ACSA2 + cells are CD45-BV605 + /CD45.2-PE – , indicating CNS-resident immune cell contamination, while only 1.54% are circulating immune cells (CD45-BV605 + /CD45.2-PE + ). (C) Isotype control using <t>IgG2b-κ-PE</t> (I.V.) shows minimal non-specific labeling confirming specificity of CD45.2 labeling. Gates set on live, nucleated DRAQ5+/DAPI- singlets. Representative plots from n = 3 mice per condition.
Rat Igg2b Pe Isotype Control, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rat igg2b pe isotype control/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
rat igg2b pe isotype control - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

95
Multi Sciences (Lianke) Biotech Co Ltd anti mouse igg
Intravenous antibody labeling distinguishes CNS-resident from circulating immune cells in ACSA2 + fractions. (A) Mice received I.V. injection of fluorescent antibody 3 min before tissue harvest and brain dissociation. I.V.-labeled cells represent circulating immune cells, while unlabeled CD45 + cells are CNS-resident. Created in BioRender. Daniele, E. (2026) https://BioRender.com/20anz0d . (B) Flow cytometry using anti-CD45.2-PE (I.V.) shows 20.3% of ACSA2 + cells are CD45-BV605 + /CD45.2-PE – , indicating CNS-resident immune cell contamination, while only 1.54% are circulating immune cells (CD45-BV605 + /CD45.2-PE + ). (C) Isotype control using <t>IgG2b-κ-PE</t> (I.V.) shows minimal non-specific labeling confirming specificity of CD45.2 labeling. Gates set on live, nucleated DRAQ5+/DAPI- singlets. Representative plots from n = 3 mice per condition.
Anti Mouse Igg, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse igg/product/Multi Sciences (Lianke) Biotech Co Ltd
Average 95 stars, based on 1 article reviews
anti mouse igg - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

95
Multi Sciences (Lianke) Biotech Co Ltd anti mouse igg antibody
Intravenous antibody labeling distinguishes CNS-resident from circulating immune cells in ACSA2 + fractions. (A) Mice received I.V. injection of fluorescent antibody 3 min before tissue harvest and brain dissociation. I.V.-labeled cells represent circulating immune cells, while unlabeled CD45 + cells are CNS-resident. Created in BioRender. Daniele, E. (2026) https://BioRender.com/20anz0d . (B) Flow cytometry using anti-CD45.2-PE (I.V.) shows 20.3% of ACSA2 + cells are CD45-BV605 + /CD45.2-PE – , indicating CNS-resident immune cell contamination, while only 1.54% are circulating immune cells (CD45-BV605 + /CD45.2-PE + ). (C) Isotype control using <t>IgG2b-κ-PE</t> (I.V.) shows minimal non-specific labeling confirming specificity of CD45.2 labeling. Gates set on live, nucleated DRAQ5+/DAPI- singlets. Representative plots from n = 3 mice per condition.
Anti Mouse Igg Antibody, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse igg antibody/product/Multi Sciences (Lianke) Biotech Co Ltd
Average 95 stars, based on 1 article reviews
anti mouse igg antibody - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

94
Developmental Studies Hybridoma Bank anti manduca sexta ecdysone igg2b
Intravenous antibody labeling distinguishes CNS-resident from circulating immune cells in ACSA2 + fractions. (A) Mice received I.V. injection of fluorescent antibody 3 min before tissue harvest and brain dissociation. I.V.-labeled cells represent circulating immune cells, while unlabeled CD45 + cells are CNS-resident. Created in BioRender. Daniele, E. (2026) https://BioRender.com/20anz0d . (B) Flow cytometry using anti-CD45.2-PE (I.V.) shows 20.3% of ACSA2 + cells are CD45-BV605 + /CD45.2-PE – , indicating CNS-resident immune cell contamination, while only 1.54% are circulating immune cells (CD45-BV605 + /CD45.2-PE + ). (C) Isotype control using <t>IgG2b-κ-PE</t> (I.V.) shows minimal non-specific labeling confirming specificity of CD45.2 labeling. Gates set on live, nucleated DRAQ5+/DAPI- singlets. Representative plots from n = 3 mice per condition.
Anti Manduca Sexta Ecdysone Igg2b, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti manduca sexta ecdysone igg2b/product/Developmental Studies Hybridoma Bank
Average 94 stars, based on 1 article reviews
anti manduca sexta ecdysone igg2b - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

94
Developmental Studies Hybridoma Bank mouse igg2b
Intravenous antibody labeling distinguishes CNS-resident from circulating immune cells in ACSA2 + fractions. (A) Mice received I.V. injection of fluorescent antibody 3 min before tissue harvest and brain dissociation. I.V.-labeled cells represent circulating immune cells, while unlabeled CD45 + cells are CNS-resident. Created in BioRender. Daniele, E. (2026) https://BioRender.com/20anz0d . (B) Flow cytometry using anti-CD45.2-PE (I.V.) shows 20.3% of ACSA2 + cells are CD45-BV605 + /CD45.2-PE – , indicating CNS-resident immune cell contamination, while only 1.54% are circulating immune cells (CD45-BV605 + /CD45.2-PE + ). (C) Isotype control using <t>IgG2b-κ-PE</t> (I.V.) shows minimal non-specific labeling confirming specificity of CD45.2 labeling. Gates set on live, nucleated DRAQ5+/DAPI- singlets. Representative plots from n = 3 mice per condition.
Mouse Igg2b, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse igg2b/product/Developmental Studies Hybridoma Bank
Average 94 stars, based on 1 article reviews
mouse igg2b - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

98
Thermo Fisher rat igg2b kappa isotype control
Intravenous antibody labeling distinguishes CNS-resident from circulating immune cells in ACSA2 + fractions. (A) Mice received I.V. injection of fluorescent antibody 3 min before tissue harvest and brain dissociation. I.V.-labeled cells represent circulating immune cells, while unlabeled CD45 + cells are CNS-resident. Created in BioRender. Daniele, E. (2026) https://BioRender.com/20anz0d . (B) Flow cytometry using anti-CD45.2-PE (I.V.) shows 20.3% of ACSA2 + cells are CD45-BV605 + /CD45.2-PE – , indicating CNS-resident immune cell contamination, while only 1.54% are circulating immune cells (CD45-BV605 + /CD45.2-PE + ). (C) Isotype control using <t>IgG2b-κ-PE</t> (I.V.) shows minimal non-specific labeling confirming specificity of CD45.2 labeling. Gates set on live, nucleated DRAQ5+/DAPI- singlets. Representative plots from n = 3 mice per condition.
Rat Igg2b Kappa Isotype Control, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rat igg2b kappa isotype control/product/Thermo Fisher
Average 98 stars, based on 1 article reviews
rat igg2b kappa isotype control - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

94
Miltenyi Biotec isotype controls
Intravenous antibody labeling distinguishes CNS-resident from circulating immune cells in ACSA2 + fractions. (A) Mice received I.V. injection of fluorescent antibody 3 min before tissue harvest and brain dissociation. I.V.-labeled cells represent circulating immune cells, while unlabeled CD45 + cells are CNS-resident. Created in BioRender. Daniele, E. (2026) https://BioRender.com/20anz0d . (B) Flow cytometry using anti-CD45.2-PE (I.V.) shows 20.3% of ACSA2 + cells are CD45-BV605 + /CD45.2-PE – , indicating CNS-resident immune cell contamination, while only 1.54% are circulating immune cells (CD45-BV605 + /CD45.2-PE + ). (C) Isotype control using <t>IgG2b-κ-PE</t> (I.V.) shows minimal non-specific labeling confirming specificity of CD45.2 labeling. Gates set on live, nucleated DRAQ5+/DAPI- singlets. Representative plots from n = 3 mice per condition.
Isotype Controls, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/isotype controls/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
isotype controls - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


The Role of CD4 + T Cells in Cardiac Functional Remodeling (A) Experimental design. (B and C) Flow cytometric analysis of CD4 + T cells in peripheral blood of TCRM mice treated with IgG2b isotype control or anti-CD4 antibody. (D) Representative H&E and PSR-stained heart sections. (E) Myocarditis score and (F) quantification of PSR-positive area, in 8-week-old TCRM mice subjected to the indicated treatment. (G to J) Echocardiographic assessment of left ventricular morphology and function in 8-week-old TCRM mice treated with isotype control or anti-CD4 antibody. (G) LVID systole, (H) LVEF, (I) GCS, (J) GLS. (C, E to J) Pooled data from 3 independent experiments, including n = 12 anti-CD4-treated TCRM mice and n = 13 isotype-treated TCRM mice of which n = 5 progressed to iCMP. Statistical analysis was performed using C, unpaired 2-tailed Student’s t -test or Mann-Whitney U test and (E to J) 1-way analysis of variance with Tukey’s post hoc test or Kruskal-Wallis test with Dunnett’s multiple comparisons test. Boxplots as in . ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001. Abbreviations as in and .

Journal: JACC: Basic to Translational Science

Article Title: Cardiopathogenic T Cells Govern Progression and Functional Remodeling in Inflammatory Cardiomyopathy and Chronic Myocarditis

doi: 10.1016/j.jacbts.2025.101458

Figure Lengend Snippet: The Role of CD4 + T Cells in Cardiac Functional Remodeling (A) Experimental design. (B and C) Flow cytometric analysis of CD4 + T cells in peripheral blood of TCRM mice treated with IgG2b isotype control or anti-CD4 antibody. (D) Representative H&E and PSR-stained heart sections. (E) Myocarditis score and (F) quantification of PSR-positive area, in 8-week-old TCRM mice subjected to the indicated treatment. (G to J) Echocardiographic assessment of left ventricular morphology and function in 8-week-old TCRM mice treated with isotype control or anti-CD4 antibody. (G) LVID systole, (H) LVEF, (I) GCS, (J) GLS. (C, E to J) Pooled data from 3 independent experiments, including n = 12 anti-CD4-treated TCRM mice and n = 13 isotype-treated TCRM mice of which n = 5 progressed to iCMP. Statistical analysis was performed using C, unpaired 2-tailed Student’s t -test or Mann-Whitney U test and (E to J) 1-way analysis of variance with Tukey’s post hoc test or Kruskal-Wallis test with Dunnett’s multiple comparisons test. Boxplots as in . ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001. Abbreviations as in and .

Article Snippet: Mice were treated with 500 μg of anti-CD4 antibody (clone: YTS191, ECACC, 87072282) or IgG2b isotype control antibody (clone: MPC-11, ECACC, ATCC CCL-167) by intraperitoneal injection twice a week as demonstrated in the respective experiments.

Techniques: Functional Assay, Control, Staining, MANN-WHITNEY

Intravenous antibody labeling distinguishes CNS-resident from circulating immune cells in ACSA2 + fractions. (A) Mice received I.V. injection of fluorescent antibody 3 min before tissue harvest and brain dissociation. I.V.-labeled cells represent circulating immune cells, while unlabeled CD45 + cells are CNS-resident. Created in BioRender. Daniele, E. (2026) https://BioRender.com/20anz0d . (B) Flow cytometry using anti-CD45.2-PE (I.V.) shows 20.3% of ACSA2 + cells are CD45-BV605 + /CD45.2-PE – , indicating CNS-resident immune cell contamination, while only 1.54% are circulating immune cells (CD45-BV605 + /CD45.2-PE + ). (C) Isotype control using IgG2b-κ-PE (I.V.) shows minimal non-specific labeling confirming specificity of CD45.2 labeling. Gates set on live, nucleated DRAQ5+/DAPI- singlets. Representative plots from n = 3 mice per condition.

Journal: Frontiers in Cellular Neuroscience

Article Title: ACSA2 is not astrocyte-specific: implications for cell sorting strategies in the rodent brain

doi: 10.3389/fncel.2026.1756677

Figure Lengend Snippet: Intravenous antibody labeling distinguishes CNS-resident from circulating immune cells in ACSA2 + fractions. (A) Mice received I.V. injection of fluorescent antibody 3 min before tissue harvest and brain dissociation. I.V.-labeled cells represent circulating immune cells, while unlabeled CD45 + cells are CNS-resident. Created in BioRender. Daniele, E. (2026) https://BioRender.com/20anz0d . (B) Flow cytometry using anti-CD45.2-PE (I.V.) shows 20.3% of ACSA2 + cells are CD45-BV605 + /CD45.2-PE – , indicating CNS-resident immune cell contamination, while only 1.54% are circulating immune cells (CD45-BV605 + /CD45.2-PE + ). (C) Isotype control using IgG2b-κ-PE (I.V.) shows minimal non-specific labeling confirming specificity of CD45.2 labeling. Gates set on live, nucleated DRAQ5+/DAPI- singlets. Representative plots from n = 3 mice per condition.

Article Snippet: Intensity thresholds were set based on background signal measured in secondary-only and a rat IgG2b-PE isotype control (1:50, Miltenyi Biotec, Cat# 130-123-273).

Techniques: Antibody Labeling, Injection, Labeling, Flow Cytometry, Control